|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:CTSD-MYH9 (FusionGDB2 ID:20497) |
Fusion Gene Summary for CTSD-MYH9 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: CTSD-MYH9 | Fusion gene ID: 20497 | Hgene | Tgene | Gene symbol | CTSD | MYH9 | Gene ID | 1509 | 4627 |
| Gene name | cathepsin D | myosin heavy chain 9 | |
| Synonyms | CLN10|CPSD|HEL-S-130P | BDPLT6|DFNA17|EPSTS|FTNS|MATINS|MHA|NMHC-II-A|NMMHC-IIA|NMMHCA | |
| Cytomap | 11p15.5 | 22q12.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | cathepsin Dceroid-lipofuscinosis, neuronal 10epididymis secretory sperm binding protein Li 130Plysosomal aspartyl peptidaselysosomal aspartyl protease | myosin-9cellular myosin heavy chain, type Amyosin, heavy chain 9, non-musclenon-muscle myosin heavy chain 9non-muscle myosin heavy chain Anon-muscle myosin heavy chain IIanon-muscle myosin heavy polypeptide 9nonmuscle myosin heavy chain II-A | |
| Modification date | 20200327 | 20200315 | |
| UniProtAcc | P07339 | P35579 | |
| Ensembl transtripts involved in fusion gene | ENST00000236671, | ENST00000216181, ENST00000475726, ENST00000401701, | |
| Fusion gene scores | * DoF score | 13 X 12 X 7=1092 | 44 X 46 X 15=30360 |
| # samples | 14 | 56 | |
| ** MAII score | log2(14/1092*10)=-2.96347412397489 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(56/30360*10)=-5.76060115335786 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: CTSD [Title/Abstract] AND MYH9 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | CTSD(1775118)-MYH9(36693031), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | CTSD | GO:0006508 | proteolysis | 16997486 |
| Hgene | CTSD | GO:0042159 | lipoprotein catabolic process | 16997486 |
| Hgene | CTSD | GO:0043065 | positive regulation of apoptotic process | 12107093 |
| Hgene | CTSD | GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process | 12107093 |
| Hgene | CTSD | GO:0070201 | regulation of establishment of protein localization | 12107093 |
| Tgene | MYH9 | GO:0001525 | angiogenesis | 16403913 |
| Tgene | MYH9 | GO:0001778 | plasma membrane repair | 27325790 |
| Tgene | MYH9 | GO:0006509 | membrane protein ectodomain proteolysis | 16186248 |
| Tgene | MYH9 | GO:0030048 | actin filament-based movement | 12237319|15845534 |
| Tgene | MYH9 | GO:0031032 | actomyosin structure organization | 24072716 |
| Fusion gene breakpoints across CTSD (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene breakpoints across MYH9 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | LUAD | TCGA-55-6712-01A | CTSD | chr11 | 1775118 | - | MYH9 | chr22 | 36693031 | - |
Top |
Fusion Gene ORF analysis for CTSD-MYH9 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-3CDS | ENST00000236671 | ENST00000216181 | CTSD | chr11 | 1775118 | - | MYH9 | chr22 | 36693031 | - |
| intron-intron | ENST00000236671 | ENST00000475726 | CTSD | chr11 | 1775118 | - | MYH9 | chr22 | 36693031 | - |
| intron-intron | ENST00000236671 | ENST00000401701 | CTSD | chr11 | 1775118 | - | MYH9 | chr22 | 36693031 | - |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for CTSD-MYH9 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for CTSD-MYH9 |
| Go to FGviewer for the breakpoints of :-: - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| CTSD | MYH9 |
| FUNCTION: Acid protease active in intracellular protein breakdown. Plays a role in APP processing following cleavage and activation by ADAM30 which leads to APP degradation (PubMed:27333034). Involved in the pathogenesis of several diseases such as breast cancer and possibly Alzheimer disease. {ECO:0000269|PubMed:27333034}. | FUNCTION: Cellular myosin that appears to play a role in cytokinesis, cell shape, and specialized functions such as secretion and capping. Promotes also cell motility together with S100A4 (PubMed:16707441). During cell spreading, plays an important role in cytoskeleton reorganization, focal contacts formation (in the margins but not the central part of spreading cells), and lamellipodial retraction; this function is mechanically antagonized by MYH10 (PubMed:20052411). {ECO:0000250|UniProtKB:Q8VDD5, ECO:0000269|PubMed:16707441, ECO:0000269|PubMed:20052411}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for CTSD-MYH9 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
Top |
Fusion Gene PPI Analysis for CTSD-MYH9 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for CTSD-MYH9 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Hgene | CTSD | P07339 | DB00071 | Insulin pork | Biotech | Approved | |
| Hgene | CTSD | P07339 | DB00071 | Insulin pork | Biotech | Approved |
Top |
Related Diseases for CTSD-MYH9 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | CTSD | C1864669 | NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCY | 4 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
| Hgene | CTSD | C0003873 | Rheumatoid Arthritis | 1 | CTD_human |
| Hgene | CTSD | C0007134 | Renal Cell Carcinoma | 1 | CTD_human |
| Hgene | CTSD | C0022658 | Kidney Diseases | 1 | CTD_human |
| Hgene | CTSD | C0027626 | Neoplasm Invasiveness | 1 | CTD_human |
| Hgene | CTSD | C0029408 | Degenerative polyarthritis | 1 | CTD_human |
| Hgene | CTSD | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
| Hgene | CTSD | C0043094 | Weight Gain | 1 | CTD_human |
| Hgene | CTSD | C0086743 | Osteoarthrosis Deformans | 1 | CTD_human |
| Hgene | CTSD | C0279702 | Conventional (Clear Cell) Renal Cell Carcinoma | 1 | CTD_human |
| Hgene | CTSD | C0376358 | Malignant neoplasm of prostate | 1 | CTD_human |
| Hgene | CTSD | C1266042 | Chromophobe Renal Cell Carcinoma | 1 | CTD_human |
| Hgene | CTSD | C1266043 | Sarcomatoid Renal Cell Carcinoma | 1 | CTD_human |
| Hgene | CTSD | C1266044 | Collecting Duct Carcinoma of the Kidney | 1 | CTD_human |
| Hgene | CTSD | C1306837 | Papillary Renal Cell Carcinoma | 1 | CTD_human |
| Hgene | CTSD | C1862939 | AMYOTROPHIC LATERAL SCLEROSIS 1 | 1 | CTD_human |
| Hgene | CTSD | C1862941 | Amyotrophic Lateral Sclerosis, Sporadic | 1 | CTD_human |
| Hgene | CTSD | C2239176 | Liver carcinoma | 1 | CTD_human |
| Hgene | CTSD | C4551993 | Amyotrophic Lateral Sclerosis, Familial | 1 | CTD_human |
| Tgene | MYH9 | C0340978 | May-Hegglin anomaly | 25 | CLINGEN;GENOMICS_ENGLAND;UNIPROT |
| Tgene | MYH9 | C1854520 | SEBASTIAN SYNDROME | 14 | CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET |
| Tgene | MYH9 | C0398641 | Epstein syndrome (disorder) | 11 | CLINGEN |
| Tgene | MYH9 | C0403445 | Fechtner syndrome (disorder) | 11 | CLINGEN |
| Tgene | MYH9 | C0477317 | Other primary thrombocytopenia | 11 | CLINGEN |
| Tgene | MYH9 | C1842035 | Giant Platelet Syndrome with Thrombocytopenia | 11 | CLINGEN |
| Tgene | MYH9 | C1863659 | DEAFNESS, AUTOSOMAL DOMINANT 17 | 6 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
| Tgene | MYH9 | C0022661 | Kidney Failure, Chronic | 2 | CTD_human |
| Tgene | MYH9 | C0006142 | Malignant neoplasm of breast | 1 | CTD_human;UNIPROT |
| Tgene | MYH9 | C0017668 | Focal glomerulosclerosis | 1 | CTD_human |
| Tgene | MYH9 | C0018784 | Sensorineural Hearing Loss (disorder) | 1 | GENOMICS_ENGLAND |
| Tgene | MYH9 | C0018965 | Hematuria | 1 | GENOMICS_ENGLAND |
| Tgene | MYH9 | C0020544 | Renal hypertension | 1 | CTD_human |
| Tgene | MYH9 | C0027626 | Neoplasm Invasiveness | 1 | CTD_human |
| Tgene | MYH9 | C0027706 | Hereditary nephritis | 1 | CTD_human |
| Tgene | MYH9 | C0033687 | Proteinuria | 1 | GENOMICS_ENGLAND |
| Tgene | MYH9 | C0035078 | Kidney Failure | 1 | GENOMICS_ENGLAND |
| Tgene | MYH9 | C0086432 | Hyalinosis, Segmental Glomerular | 1 | CTD_human |
| Tgene | MYH9 | C0086543 | Cataract | 1 | GENOMICS_ENGLAND |
| Tgene | MYH9 | C0206692 | Carcinoma, Lobular | 1 | CTD_human |
| Tgene | MYH9 | C0410005 | Nodular fasciitis | 1 | ORPHANET |
| Tgene | MYH9 | C0678222 | Breast Carcinoma | 1 | CTD_human |
| Tgene | MYH9 | C1257931 | Mammary Neoplasms, Human | 1 | CTD_human |
| Tgene | MYH9 | C1458155 | Mammary Neoplasms | 1 | CTD_human |
| Tgene | MYH9 | C1567741 | Alport Syndrome | 1 | CTD_human |
| Tgene | MYH9 | C1567742 | Alport Syndrome, X-Linked | 1 | CTD_human |
| Tgene | MYH9 | C1567743 | Alport Syndrome, Autosomal Dominant | 1 | CTD_human |
| Tgene | MYH9 | C1567744 | Alport Syndrome, Autosomal Recessive | 1 | CTD_human |
| Tgene | MYH9 | C1834478 | MACROTHROMBOCYTOPENIA AND PROGRESSIVE SENSORINEURAL DEAFNESS | 1 | CTD_human |
| Tgene | MYH9 | C2931861 | Hemorrhagic hereditary nephritis | 1 | CTD_human |
| Tgene | MYH9 | C4280711 | Leukocyte inclusion bodies | 1 | GENOMICS_ENGLAND |
| Tgene | MYH9 | C4704874 | Mammary Carcinoma, Human | 1 | CTD_human |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies